Acurx Pharmaceuticals (ACXP) Selling, General & Administrative (2020 - 2026)
Acurx Pharmaceuticals' Selling, General & Administrative was $1.24 million in Q2 2026, down 29.2% from $1.75 million a year earlier and down 10.1% from the prior quarter.
Powered by 
Analysis
Acurx Pharmaceuticals (ACXP) Selling, General & Administrative (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acurx Pharmaceuticals' Selling, General & Administrative was $5.54 million through Jun 30, 2026, down 19.9% year-over-year; for FY2025, it came in at $6.26 million, down 28.2% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $8.72 million in FY2024 (+2.2%), $8.53 million in FY2023 (+16.3%), $7.34 million in FY2022 (-32.0%) and $10.78 million in FY2021 (+349.9%).
- The Q2 2026 figure marks the lowest quarterly Selling, General & Administrative since Q4 2020.
- Compared with a year earlier, Selling, General & Administrative has declined for eight straight quarters, with an average decline of 23.7% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 437.0%); the worst was Q2 2022 (a decline of 57.0%).
- Per Business Quant data, ACXP's Selling, General & Administrative in the three quarters before Q2 2026 was $1.37 million (Q1 2026), $1.34 million (Q4 2025) and $1.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Acurx Pharmaceuticals | 5.90 Mn | 5.90 Mn | - | 1.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.82 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.85 Mn |
| Dec 31, 2021 | 1.91 Mn |
| Sep 30, 2021 | 3.52 Mn |
API Access
Acurx Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ACXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();